Opportunity
As an early-stage AI business operating in a highly specialised and regulated field, MyCardium AI needed more than routine accountancy support. The Liverpool-headquartered University College of London (UCL) spinout develops technology that uses AI to measure cardiac function from ultrasound imaging, helping clinicians to assess heart conditions and inform treatment decisions. Its software is delivered to hospitals globally and supports pharmaceutical companies in understanding the impact of new drugs.
With 35 employees and ambitious growth plans, MyCardium AI needed an adviser that could support the business with all aspects of accountancy and compliance from the outset. That meant putting the right company structure in place, managing core compliance requirements and ensuring the business was meeting the regulatory requirements needed for an R&D-intensive company in the health tech sector.
Having worked with DSG since 2022, the business sought a partner that could combine technical expertise with a strong understanding of the Liverpool business ecosystem. For a fast-moving innovation business, responsiveness and considered advice were key.
Strategy
DSG has supported MyCardium AI across compliance, accounts, business advisory, tax advisory and company structure, helping the business lay the foundations for long term, sustainable growth.
For an evolving AI and life sciences business, financial advice needs to do more than keep pace with reporting deadlines. It should reflect the realities of a company driven by innovation and where investment cycles, R&D activity, and changing operational needs all shape decision-making. DSG’s role has evolved with the business, widening to include support around R&D to help the business get the most value out of incentives, setting it up for future success.
This has been particularly important as the company has matured. Since MyCardium AI appointed its own CFO, DSG has adapted its support to complement the in-house finance function, providing the specialist advice needed while remaining flexible to business needs.
“DSG has been a key strategic partner in our growth over the past few years,” said Antony Shimmin, co-founder and COO at MyCardium AI. “The team are responsive, personable and proactive, and they have guided us through every stage of our growth journey so far. Having the expertise of DSG to advise on the growth of our company has allowed us to focus in on in the delivery of our services to a global market”.
Result
The partnership has given MyCardium AI the financial and advisory support needed to grow with confidence in a complex and fast paced sector. With robust compliance, clear business advice and adaptable tax support in place, the company has the financial visibility to make key decisions at pivotal moments.
